The US Food and Drug Administration has okayed only one antiviral medicine for treating Respiratory Syncytial Virus, which needs to be delivered to the patient through a nebulizer. iStock by BonNontawat/Getty Images Plus. Many moms and dads may be unfamiliar with Respiratory Syncytial Virus (RSV) in light of the noteworthy number of hospitalizations it has caused among little ones during autumn of 2022. RSV is a kind of virus that usually appears from late fall to early winter, and it is frequently the source of lung illnesses in infants. Symptoms of RSV are consistent with other respiratory infections, such as a runny nose, sneezing, coughing, congestion, fever, lack of appetite, and wheezing, making it hard to tell the difference. Generally, RSV is usually not serious and can be treated at home. In some cases, RSV can be quite dangerous, to the point where a hospital stay is necessary. People of all ages, from the elderly to those with weakened immune systems or chronic health problems like lung and heart disease, can become seriously ill with RSV and suffer infections or pneumonia. RSV is a frequent respiratory danger, primarily affecting young kids, and is observed by epidemiologists and pediatric infectious disease physicians. Unfortunately, treatments for RSV are restricted and currently, there is no vaccine available. It appears that 2023 will be an essential year for RSV control plans and therapies. Therefore, it is advisable to take precautions to protect your youngster from contracting RSV. Additionally, looking into methods to treat RSV in children may be beneficial.
